Skip to the page

Data / Form D filings / Inductive Bio, Inc.

Inductive Bio, Inc.: Form D filing

Inductive Bio, Inc., a technology company in Brooklyn, NY, filed a Form D with the SEC in 2025. The latest, on May 7, 2025, reports $25.1 million sold of a $25.1 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
550 VANDERBILT AVE #730, Brooklyn, NY, 11238
Phone
(646) 229-7139
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2065009

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 7, 2025New notice$25,105,347$25,105,34710Mar 21, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Benjamin Edward BirnbaumExecutive Officer, Director
Joshua Daniel HaimsonExecutive Officer, Director
Rohan Edward GaneshDirector

Other technology companies in New York that filed recently

Every Form D from the week of May 5, 2025 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Inductive Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.